2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Fong W. Lam, Non-Member Physician (he/him/his)

Baylor College of Medicine, Texas

As a Pediatric Intensivist-Scientist, I care for children with critical illness as well as make biomedical discoveries that underly the pathophysiology of their disease, particularly inflammation and thrombosis, and its treatment. My overall career goal is to reduce the morbidity and mortality in critically ill patients by using and enhancing my clinical, educational, and research expertise.

I am board-certified in General Pediatrics and Pediatric Critical Care Medicine. I am the Co-Director of the TCH Liver Intensive Care Unit (LICU), a transformative group started in 2014 in which a multidisciplinary team of Liver Transplant Surgeons, Hepatologists, and others work together to maximize the outcome for critically ill children with liver failure. The LICU is a novel concept and one in which we have had success in reducing the peri-transplant mortality of patients with liver failure. I am also an attending physician of the TCH Extracorporeal Membrane Oxygenation (ECMO) team, performing both clinical care and biomedical research to improve outcomes for patients receiving ECMO.

I am deeply passionate about the education of Pediatric Intensivists. As an Associate Program Director of our Pediatric Critical Care Medicine Fellowship Program, I developed a recurring year-long curriculum for our medical trainees and advanced practice providers, both at BCM/TCH and in Pediatric Critical Care Medicine Fellowship Programs across the country. I am also the Program Director of our LICU Instructorship Program, providing additional clinical and research expertise in critical liver failure.

Finally, as a NIH-funded Physician-Scientist, my research passion lies within the interactions between neutrophils, platelets, and endothelial cells within the microcirculation and how they regulate thromboinflammation. My laboratory is working on three areas: (1) developing novel proteins to attenuating inflammation and viral illness, (2) testing novel apheresis microfluidic devices in vitro and in vivo, and (3) further identifying platelets’ roles in microvascular inflammation and thrombosis.

Presentation(s):